Multicohort model for prevalence estimation of advanced malignant melanoma in the USA: An increasing public health concern

Melanoma Research

Volumn 22, Issue 6, 2012, Pages 454-459

  Lin, Amy Y ^a   Wang, Peter F ^b   Li, Haojie ^b   Kolker, Jennifer A ^a  

^a DREXEL UNIVERSITY   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

advanced malignant melanoma; cancer prevalence; health outcomes; malignant melanoma; outcomes model; prevalence projection

Indexed keywords

ADULT; ADVANCED CANCER; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CAUSE OF DEATH; CONTROLLED STUDY; CUTANEOUS MELANOMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; POPULATION RESEARCH; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; SEX DIFFERENCE; STRATIFIED SAMPLE; UNITED STATES;

COHORT STUDIES; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; PREVALENCE; PUBLIC HEALTH; RISK FACTORS; SKIN NEOPLASMS; UNITED STATES;

EID: 84869497895     PISSN: 09608931     EISSN: 14735636     Source Type: Journal    
DOI: 10.1097/CMR.0b013e328358d96f     Document Type: Article

References (17)

1. Robinson JK. Sun exposure, sun protection, and vitamin D. JAMA 2005; 294:1541-1543.
2. Jemal A, Siegel R, Xu J,Ward E. Cancer Statistics, 2010. CA Cancer J Clin 2010; 60:277-300.
3. Markovic SN, Erickson LA, Rao RD,Weenig RH, Pockaj BA, Bardia A, et al. Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin Proc 2007; 82:364-380.
4. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, et al. SEER cancer statistics review, 1975-2008 2011;Bethesda, MD:National Cancer Institute; Available at: http://seer.cancer.gov/csr/1975-2008/[Accessed 30 May 2011].
5. Linos E, Swetter SM, Cockburn MG, Colditz GA, Clarke CA. Increasing Burden of Melanoma in the United States. J Invest Dermatol 2009; 129:1666-1674.
6. Rigel DS, Russak J, Friedman R. The evolution of melanoma diagnosis: 25 years beyond the ABCDs. CA Cancer J Clin 2010; 60:301-316.
7. Slingluff CL Jr, Flaherty K, Rosenberg SA, Read RW. Cutaneous melanoma. In: DeVita VT Jr, Lawrence TS, Rosenberg SA, editors. DeVita, Hellman, and Rosenberg's Cancer: principles & practice of oncology. Philadelphia, PA: Lippincott Williams and Wilkins; 2011. p. 1645.
8. Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009; 27:6199-6206.
9. American Cancer Society. Cancer facts & figures 2010. Atlanta: American Cancer Society; Available at: http://www.cancer.org/acs/groups/content/ @nho/documents/document/acspc-024113.pdf [Accessed 30 May 2011] .
10. Scosyrev E, Messing J, Noyes K, Veazie P, Messing E. Surveillance Epidemiology and End Result (SEER) program and population-based research in urologic oncology: an overview. Urol Oncol 2010; 30:126-132.
11. US Census Bureau, US Population Projections (12 January 2007). Available at: http://www.census.gov/population/www/projections/2009projections.html [Accessed 30 January 2011].
12. Francken AB, Accortt NA, Shaw HM, Colman MH, Wiener M, Soong SJ. Follow-up schedules after treatment for malignant melanoma. Br J Surg 2008; 95:1401-1407.
13. Romano E, Scordo M, Dusza SW, Coit DG, Chapman PB. Site and time of first relapse in stage III melanoma patients: implications for follow-up guidelines. J Clin Oncol 2010; 28:3042-3047.
14. Poo-Hwu WJ, Ariyan S, Lamb L, Papac R, Zelterman D, Hu GL, et al. Follow-up recommendations for patient with American Joint Committee on Cancer Stages I-III Malignant Melanoma. Cancer 1999; 88:2252-2258.
15. Joosse A, de Vries E, Eckel R, Nijsten T, Eggermont AM, Holzel D, et al. Gender differences in melanoma survival: female patients have a decreased risk of metastasis. J Invest Dermatol 2011; 131:719-726.
16. Capocaccia R, Colonna M, Corazziari I, De Angelis R, Francisci S, Micheli A, et al. Measuring cancer prevalence in Europe: the EUROPREVAL project. Ann Oncol 2002; 13:831-839.
17. Pisani P, Bray F, Parkin DM. Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer 2002; 97:72-81.